Hypogammaglobulinemia and Infection Events in Patients with Autoimmune Diseases Treated with Rituximab: 10 Years Real-Life Experience - Nie, Yuxue; Zhang, Nianyi; Li, Jingna; Wu, Di; Yang, Yunjiao; Zhang, Li; Bai, Wei; Jiang, Nan; Qiao, Lin; Huang, Can; Zhou, Shuang; Tian, Xinping; et al. (Journal of clinical immunology, 2024)
Keywords: Adult; Agammaglobulinemia - epidemiology; Aged; Antineutrophil cytoplasmic antibodies; Autoimmune diseases; Autoimmune Diseases - complications; Autoimmune Diseases - drug therapy; Biomedical and Life Sciences; Biomedicine; China; China - epidemiology; Connective tissue diseases; Disease; Female; glucocorticoids; Glucocorticoids - therapeutic use; Humans; Hypogammaglobulinemia; Immunoglobulin G; Immunoglobulin G - blood; Immunoglobulin M; Immunology; Immunotherapy; Infections - epidemiology; Infections - etiology; Infectious Diseases; Internal Medicine; Lung diseases; Male; medical facilities; Medical Microbiology; Middle Aged; Monoclonal antibodies; Patients; Population studies; Prednisone; respiratory tract diseases; Retrospective Studies; Risk Factors; Rituximab; Rituximab - adverse effects; Rituximab - therapeutic use; therapeutics; Vasculitis; China; Rituximab; Autoimmune disease; Immunoglobulins; Hypogammaglobulinemia; Severe infection event